Rachel Haurwitz is co-founder, president and CEO of Caribou Biosciences. In her discussion with Nature Biotechnology, she explains what drew her into the sciences, how her father's journalism career brought their family to Austin, Texas, and how she found herself at the cutting edge of CRISPR technology. http://www.nature.com/nbt/podcast/index.html
Rights and permissions
About this article
Cite this article
First Rounders: Rachel Haurwitz. Nat Biotechnol 35, 405 (2017). https://doi.org/10.1038/nbt.3862
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3862